tiprankstipranks
Trending News
More News >
Ascelia Pharma AB (DE:7ZA)
:7ZA
Germany Market

Ascelia Pharma AB (7ZA) Ratios

Compare
2 Followers

Ascelia Pharma AB Ratios

DE:7ZA's free cash flow for Q4 2024 was kr0.00. For the 2024 fiscal year, DE:7ZA's free cash flow was decreased by kr and operating cash flow was kr0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
20.54 2.30 4.29 10.94 10.69
Quick Ratio
20.54 2.30 4.11 10.94 10.69
Cash Ratio
13.39 1.74 3.99 10.42 10.06
Solvency Ratio
-3.28 -8.49 -3.45 -4.87 -5.07
Operating Cash Flow Ratio
-2.71 -10.09 -3.34 -4.64 -4.66
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 23.44 25.06
Net Current Asset Value
kr 218.73Mkr 16.19Mkr 123.16Mkr 248.95Mkr 177.01M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.04 1.17 1.21 1.08 1.08
Debt Service Coverage Ratio
-1.12K -7.73K -2.71K 25.49 28.78
Interest Coverage Ratio
-1.13K -7.92K -3.06K -1.79K -7.19K
Debt to Market Cap
0.00 0.00 0.00 >-0.01 >-0.01
Interest Debt Per Share
0.01 0.03 0.02 0.05 0.07
Net Debt to EBITDA
3.99 0.19 1.13 2.02 1.85
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
98.89%99.71%98.55%97.21%98.95%
EBT Per EBIT
100.43%98.82%90.58%93.89%106.76%
Return on Assets (ROA)
-12.92%-125.51%-60.04%-37.75%-38.65%
Return on Equity (ROE)
-13.45%-147.03%-72.55%-40.90%-41.81%
Return on Capital Employed (ROCE)
-13.54%-148.87%-81.20%-44.73%-39.42%
Return on Invested Capital (ROIC)
-13.39%-146.70%-79.89%-44.03%-39.44%
Return on Tangible Assets
-16.12%-364.32%-81.25%-45.55%-49.77%
Earnings Yield
-10.98%-96.18%-26.09%-12.80%-6.66%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.00
Payables Turnover
0.59 0.69 0.25 1.42 0.21
Inventory Turnover
0.00 0.00 0.57 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
-621.49 -530.62 -853.04 -257.21 -1.72K
Days of Sales Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 636.31 0.00 0.00
Days of Payables Outstanding
621.49 530.62 1.49K 257.21 1.72K
Operating Cycle
0.00 0.00 636.31 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-1.77 -3.76 -3.72 -3.54 -3.26
Free Cash Flow Per Share
-1.77 -3.76 -3.72 -3.54 -3.27
CapEx Per Share
0.00 0.00 <0.01 <0.01 0.02
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 -1.93K -3.07K -215.43
Capital Expenditure Coverage Ratio
0.00 0.00 -1.93K -3.07K -215.43
Operating Cash Flow Coverage Ratio
-207.76 -119.62 -258.81 -70.43 -48.10
Operating Cash Flow to Sales Ratio
0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-8.97%-111.58%-24.92%-11.85%-5.80%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-9.11 -1.04 -3.83 -7.81 -15.01
Price-to-Sales (P/S) Ratio
0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
1.23 1.53 2.78 3.20 6.28
Price-to-Free Cash Flow (P/FCF) Ratio
-11.15 -0.90 -4.01 -8.44 -17.24
Price-to-Operating Cash Flow Ratio
-11.15 -0.90 -4.02 -8.44 -17.32
Price-to-Earnings Growth (PEG) Ratio
-0.09 0.06 -1.83 -4.90 -0.14
Price-to-Fair Value
1.23 1.53 2.78 3.20 6.28
Enterprise Value Multiple
-5.02 -0.86 -2.68 -5.64 -13.13
Enterprise Value
188.46M 92.84M 353.93M 723.89M 1.30B
EV to EBITDA
-5.02 -0.86 -2.68 -5.64 -13.13
EV to Sales
0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
-6.21 -0.73 -2.82 -6.21 -15.12
EV to Operating Cash Flow
-6.21 -0.73 -2.83 -6.21 -15.19
Tangible Book Value Per Share
12.75 0.51 3.68 7.61 6.81
Shareholders’ Equity Per Share
16.08 2.20 5.37 9.34 8.99
Tax and Other Ratios
Effective Tax Rate
0.01 <0.01 0.01 0.03 0.01
Revenue Per Share
0.00 0.00 0.00 0.00 0.00
Net Income Per Share
-2.16 -3.24 -3.90 -3.82 -3.76
Tax Burden
0.99 1.00 0.99 0.97 0.99
Interest Burden
1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.81 1.16 0.85 0.84 0.92
Currency in SEK
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis